Sign Up Now For
Other Treatments
Some prostate cancer treatments don’t fall neatly into a category such as “radiation therapy” or “hormone therapy.” These include high-intensity focused ultrasound (HIFU), an investigational treatment that uses sound waves to destroy cancerous tissue, and cryotherapy, which kills cancer cells by freezing them. For cases of advanced, metastatic disease, your doctor may recommend chemotherapy or the recently approved prostate cancer “vaccine.”
Related Articles
Heart drug may fight prostate cancer
Digoxin (Lanoxin), a drug long used to treat heart failure and heart rhythm abnormalities, may control prostate cancer.
Read more »FDA approves abiraterone for advanced prostate cancer
The drug, approved at the end of April 2011, may be helpful for men with metastatic disease that no longer responds to hormone therapy.
Read more »Experimental drug seems safe, effective against prostate cancer
A study published in the journal Lancet found that the experimental drug MDV3100 is both safe and effective for prostate cancer patients with advanced disease that no longer responds to hormone therapy.
Read more »Prostate cancer vaccine approved by the FDA
Sipuleucel-T (Provenge), a “vaccine” that uses a patients immune system to fight advanced stage disease, was approved by the FDA in April 2010. The vaccine does not prevent cancer; rather, it helps men with advanced stage, hormone-resistant disease live longer.
Read more »HIFU controls recurrent cancer in short run
Researchers find that high-intensity focused ultrasound (HIFU) may be effective in treating localized recurrent prostate cancer while also minimizing the chances of side effects.
Read more »Experimental therapies for prostate cancer
Androgen deprivation, whether through surgical removal of the testicles or with medication, is an effective treatment for recurring prostate cancer — at least for a while. An improved understanding of the biology of prostate cancer has led to the development of two drugs that might slow disease progression in prostate cancer patients whose disease no longer responds to androgen deprivation.
Read more »Experimental drug shows promise against prostate cancer
An experimental drug may halt the production of male hormones in the body, making it a promising treatment for prostate cancer patients whose tumors have not responded to other therapies. Preliminary studies showed shrinking tumors and drops in PSA levels.
Read more »Investigational vaccine aids patients with metastatic prostate cancer
A new prostate cancer vaccine may give hope to men with metastatic prostate cancer by spurring their immune systems to fight the disease, according to a presentation by Iowa researchers at the American Urological Association’s annual meeting in May 2008. Enabling a patient’s immune system to attack cancer cells can improve quality of life and extend survival.
Read more »Drug combo may fight prostate cancer
Research shows that combining the anti-inflammatory drug celecoxib (Celebrex) and the cholesterol-lowering statin drug atorvastatin (Lipitor) halted the progression of prostate tumors in mice. Investigators are now planning to test the combo in prostate cancer patients.
Read more »Focal therapy for prostate cancer?
Two teams of researchers suggest that focal therapy may be a promising treatment option for men with cancer confined to the prostate. However, more research is needed to determine its long-term effectiveness.
Read more »